MLK4 signaling in DNA damage response and cancer therapy
2021/41/N/NZ3/02997
Keywords
Descriptors
- NZ5_003: Patogeneza chorób człowieka
- NZ3_001: Biologia komórki
- NZ3_007: Przekaźnictwo sygnału
Panel
NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution
Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 20 – announced on 2021-03-15
- Amount awarded
- 139 080 PLN
- Project start date
- 2022-01-21
- Project end date
- 2025-01-20
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease
- Authors:
- Dawid Mehlich, Anna A. Marusiak
- Academic press:
- Cancer Letters (year: 2022, volume: 547, pages: 215775), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.canlet.2022.215775 – link to the publication